StockNews.AI
EHC
StockNews.AI
26 days

Encompass Health increases and declares dividend on common stock

1. EHC's board approved a dividend increase of $0.02 per share. 2. The new quarterly cash dividend will be $0.19, payable in October 2025. 3. EHC operates 169 rehabilitation hospitals across the U.S. and Puerto Rico. 4. Ranked by Fortune as one of the world's most admired companies. 5. The company faces potential risks from regulatory changes and economic conditions.

7m saved
Insight
Article

FAQ

Why Bullish?

The increase in dividends signals financial strength and shareholder confidence, likely attracting investors. Historical evidence shows dividend increases typically correlate with stock price appreciation.

How important is it?

The article directly impacts EHC through its announcement of dividend increase, which can boost investor confidence and stock price.

Why Short Term?

Immediate investor interest may drive up EHC's stock price due to the upcoming dividend announcement. In the past, similar announcements have led to short-term gains.

Related Companies

HCAUHSCCI
, /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors approved an increase in the Company's quarterly dividend of $0.02 and declared a quarterly cash dividend on its common stock of $0.19 per share, payable on Oct. 15, 2025, to holders of record on Oct. 1, 2025. About Encompass HealthEncompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 169 hospitals in 38 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is ranked as one of Fortune's World's Most Admired Companies™ and Forbes' Most Trusted Companies in America. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook. From Fortune. © 2025 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health. From Forbes © 2024 Forbes Media LLC. All rights reserved. Used under license. Forward-Looking StatementsStatements contained in this press release which are not historical facts, such as the timing and amounts of dividends, are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking statements speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking statements, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, a decision by the board of directors to change the dividend rate in the future; the legal, regulatory and administrative developments that occur at the federal, state and local levels; general conditions in the economy and capital markets, including any instability or uncertainty related to armed conflict or an act of terrorism, governmental impasse over approval of the United States federal budget, an increase in the debt ceiling, or an international sovereign debt crisis; Encompass Health's ability to comply with extensive, complex, and ever-changing regulations in the healthcare industry; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including Encompass Health's Form 10‑K for the year ended December 31, 2024, and Form 10-Q for the quarter ended Mar. 31, 2025. Media contact:Polly Manuel | 205-970-5912[email protected] Investor relations contact:Mark Miller | 205-970-5860[email protected] SOURCE Encompass Health Corp. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News